Submitting OIG:
Report Description:
We conducted this audit because OIG had identified ensuring the safety and effectiveness of medical devices and fostering a culture of cybersecurity as top management challenges for HHS. We also considered public and Congressional interest in medical device cybersecurity risks to patients and the Internet of Things. The Food and Drug Administration (FDA) is the HHS operating division responsible for assuring that legally marketed medical devices are safe and effective.
Date Issued:
Monday, October 29, 2018
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-18-16-30530
Component, if applicable:
Food and Drug Administration
Location(s):
Agency-Wide
Type of Report:
Audit
Questioned Costs:
$0
Funds for Better Use:
$0
Number of Recommendations:
4
View Document:
Attachment | Size |
---|---|
181630530.pdf | 6.15 MB |
Additional Details Link: